Abbott Laboratories' (NYSE:ABT) stock up by 8.7% over the past three months. Since the market usually pay for a company’s long-term financial health, we decided to study the company’s fundamentals to ...

In the latest market close, Abbott (ABT) reached $113.70, with a -0.39% movement compared to the previous day. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow experienced a rise ...

The fragility of the infant formula market is being tested again — this time by legal fights over safety labeling. The big ...

The use of an oral nutrition supplement for over six months has shown improvements in protein, calcium, and vitamin B12 ...

Piper Sandler initiated coverage on Abbott Laboratories (NYSE:ABT) with an "overweight" rating and a price target of $131 per ...

The suits claim that cow-based formula, when given to premature infants, has a high risk of causing necrotizing enterocolitis, which causes the death of bowel tissue. Abbott strongly disagrees ...

But how about Big Formula? Infant formula is a billion-dollar industry with an insular market. Only a handful of ...

The Sox’ first of three against the Twins on Friday was as forgettable as they come, falling short in extras as the offensive ...

High Tide Inc. (HITI) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to loss of $0.03 per share a year ago. These ...

VIENNA (Austria) - UN nuclear watchdog IAEA holds annual General Conference PICTURE. VIDEO. LIVE VIDEO. (To 20) PARIS (France) - World Space Business Week organised by Novaspace (To 20) ...

Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech ...